Literature DB >> 6224481

The effect of dantrolene on skeletal-muscle sarcoplasmic-reticulum function in malignant hyperpyrexia in pigs.

M D White, J G Collins, M A Denborough.   

Abstract

The effect of the muscle relaxant dantrolene on isolated sarcoplasmic reticulum was studied in control and malignant-hyperpyrexia-susceptible Landrace pigs. The membranes prepared from both sources showed similar Ca2+-dependent ATPase activities, had comparable phospholipid/protein ratios, and their sodium dodecyl sulphate/polyacrylamide-gel patterns were indistinguishable. Membranes from both sources appeared to bind similar amounts of dantrolene. The drug did not stimulate Ca2+-dependent ATPase activity in preparations from either source. The rates of Ca2+ exchange and Ca2+ efflux appeared to be similar in sarcoplasmic reticulum of control and malignant-hyperpyrexia-susceptible pigs. Dantrolene did not affect either the rates or the amount of Ca2+ lost from the vesicles. These results suggest that dantrolene does not directly affect the movement of Ca2+ across the sarcoplasmic-reticulum membrane.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6224481      PMCID: PMC1152060          DOI: 10.1042/bj2120399

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.

Authors:  G G Harrison
Journal:  Br J Anaesth       Date:  1975-01       Impact factor: 9.166

2.  Studies on normal human skeletal muscle in relation to the pathopharmacology of malignant hyperpyrexia.

Authors:  T E Nelson; M A Denborough
Journal:  Clin Exp Pharmacol Physiol       Date:  1977 May-Jun       Impact factor: 2.557

3.  Site of action of dantrolene in frog sartorius muscle.

Authors:  J W Putney; C P Biancri
Journal:  J Pharmacol Exp Ther       Date:  1974-04       Impact factor: 4.030

4.  Studies on the mechanism of action of dantrolene sodium. A skeletal muscle relaxant.

Authors:  K O Ellis; J F Carpenter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

5.  Excitation-contraction uncoupling in skeletal muscle by dantrolene sodium.

Authors:  K O Ellis; S H Bryant
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

6.  Dantrolene, a direct acting skeletal muscle relaxant.

Authors:  K O Ellis; A W Castellion; L J Honkomp; F L Wessels; J E Carpenter; R P Halliday
Journal:  J Pharm Sci       Date:  1973-06       Impact factor: 3.534

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Treatment of porcine malignant hyperpyrexia. The successful use of dantrolene in the Pietrain pig.

Authors:  G M Hall; J N Lucke; D Lister
Journal:  Anaesthesia       Date:  1977-05       Impact factor: 6.955

9.  Calcium release from skeletal muscle sarcoplasmic reticulum: site of action of dantrolene sodium.

Authors:  W B Van Winkle
Journal:  Science       Date:  1976-09-17       Impact factor: 47.728

10.  The mechanism of action of dantrolene sodium.

Authors:  K G Morgan; S H Bryant
Journal:  J Pharmacol Exp Ther       Date:  1977-04       Impact factor: 4.030

View more
  5 in total

1.  Ca2+ signaling in the transformation of promastigotes to axenic amastigotes of Leishmania donovani.

Authors:  A Prasad; S Kaur; N Malla; N K Ganguly; R C Mahajan
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

Review 2.  Malignant hyperthermia: molecular defects in membrane permeability.

Authors:  K S Cheah; A M Cheah
Journal:  Experientia       Date:  1985-05-15

Review 3.  Pharmacology of calcium release from sarcoplasmic reticulum.

Authors:  P Palade; C Dettbarn; D Brunder; P Stein; G Hals
Journal:  J Bioenerg Biomembr       Date:  1989-04       Impact factor: 2.945

Review 4.  Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.

Authors:  A Ward; M O Chaffman; E M Sorkin
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

5.  Skeletal muscle excitation-contraction coupling. I. Transverse tubule control of peeled fiber Ca2+-induced Ca2+ release in normal and malignant hyperthermic muscles.

Authors:  S K Donaldson; E M Gallant; D A Huetteman
Journal:  Pflugers Arch       Date:  1989-05       Impact factor: 3.657

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.